Clinical Trials
213 trialsMK-4280A-007
Merck Sharp & Dohme LLC
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery
Alliance for Clinical Trials in Oncology
GRECCAR 5
University Hospital, Bordeaux
Comparison of A140 and Erbitux Combined With mfolfox6 to Evaluate Efficacy and Safety of First-line Treatment for Ras Wild-type mCRC
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
CodeBreak300
Amgen
PANEX3
University Hospital, Caen
COLOCROSS
Centre Oscar Lambret
00-046
Memorial Sloan Kettering Cancer Center
RECITE
Amgen
INCISIVE
University Hospital, Rouen
MK-7902-017
Merck Sharp & Dohme LLC
ALTAIR
National Cancer Center Hospital East
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
Sun Yat-sen University
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
A Study of Coformulated Favezelimab/Pembrolizumab (MK-4280A) Versus Standard of Care in Subjects With Previously Treated Metastatic PD-L1 Positive Colorectal Cancer (MK-4280A-007)-China Extension Study
Merck Sharp & Dohme LLC
RIFIONA
Centre Hospitalier Universitaire, Amiens
The Possible Protective Role of Omeprazole Against Oxaliplatin Induced Neuropathy in Cancer Patients
Tanta University
ColoRectal Cancer Screening for Southern California Community Health Centers
University of California, San Diego
PROTINCOL
Galician Research Group on Digestive Tumors
CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer
Taizhou Mabtech Pharmaceutical Co.,Ltd
AIO-KRK-0114
Ludwig-Maximilians - University of Munich
FRESCO-2
Hutchmed
CAIRO5
Dutch Colorectal Cancer Group
ITACa
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
A Clinical Study to Compare the Efficacy, Safety and Immunogenicity of HLX04 and Bevacizumab Combined XELOX or mFOLFOX6 in the First-line Treatment of mCRC
Shanghai Henlius Biotech
LYNK-003
Merck Sharp & Dohme LLC
KEYNOTE-177
Merck Sharp & Dohme LLC
SUNLIGHT
Taiho Oncology, Inc.
RECOURSE
Taiho Oncology, Inc.
RAMTAS
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
PRECONNECT
Servier
Predictors of Physical Activity Maintenance in Colorectal Cancer Survivors
University of Colorado, Denver
The Impact of Metformin Administration on the Clinical Outcome of Stage IV Colon Cancer
Ain Shams University
BEACON CRC
Pfizer
CanStem303C
Sumitomo Pharma America, Inc.
PARADIGM
Takeda
BBI608 and Best Supportive Care vs Placebo and Best Supportive Care in Pretreated Advanced Colorectal Carcinoma
Canadian Cancer Trials Group
Cetuximab + Best Supportive Care Compared With Best Supportive Care Alone in Metastatic Epidermal Growth Factor Receptor-Positive Colorectal Cancer
Canadian Cancer Trials Group
Cetuximab With or Without Brivanib in Treating Patients With K-Ras Wild Type Tumours and Metastatic Colorectal Cancer
Canadian Cancer Trials Group
Vitality
Sun Yat-sen University
Octreotide Compared With Loperamide Hydrochloride for Chemotherapy-Related Diarrhea in Patients With Colorectal Cancer
Eastern Cooperative Oncology Group
Safety and Efficacy Study of XELOX vs. Oxaliplatin+5-FU CI as First Line Treatment in Metastatic Colorectal Cancer
Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
OBELICS
National Cancer Institute, Naples
TRIPLETE
Gruppo Oncologico del Nord-Ovest
A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Chinese Patients With Metastatic Colorectal Cancer.
Hoffmann-La Roche
Donafenib for Previously Treated Metastatic Colorectal Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Evaluating Panitumumab (ABX-EGF) Plus Best Supportive Care Versus Best Supportive Care in Patients With Metastatic Colorectal Cancer
Amgen
PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy
Amgen
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity in Patients With Colon Cancer or Rectal Cancer Receiving Oxaliplatin-Based Combination Chemotherapy
Alliance for Clinical Trials in Oncology
Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone
Amgen